Table 5 ORs (95% CIs) of Hypertension when plasma markers used as continuous variables.
Biomarkers | Entire population | Men | Women | ||||||
|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
hs-CRP (mg/L) | 0.997 | 0.98–1.01 | 0.681 | 1.00 | 0.98–1.02 | 0.985 | 0.99 | 0.97–1.02 | 0.460 |
HCY (µmol/L) | 1.02 | 1.01–1.04 | 0.010 | 1.03 | 1.01–1.05 | 0.008 | 1.01 | 1.00–1.04 | 0.038 |
NT-proBNP (ng/mL) | 1.00 | 1.00–1.00 | 0.669 | 1.00 | 1.00–1.00 | 0.963 | 1.04 | 1.02–1.06 | 0.001 |
25-OHD (nmol/L) | 1.00 | 0.99–1.01 | 0.887 | 1.00 | 0.99–1.02 | 0.783 | 1.00 | 0.98–1.01 | 0.545 |
HBA1C (%) | 1.24 | 1.12–1.36 | <0.001 | 1.23 | 1.07–1.43 | 0.005 | 1.25 | 1.10–1.43 | 0.001 |
hs-TnT (ng/L) | 1.00 | 0.99–1.01 | 0.984 | 1.00 | 0.99–1.01 | 0.745 | 0.99 | 0.97–1.02 | 0.438 |
SUA (µmol/L) | 1.00 | 1.00–1.00 | 0.350 | 1.00 | 1.00–1.00 | 0.900 | 1.00 | 1.00–1.00 | 0.380 |
